Select Conferences

News Headlines

Alnylam Awarded Continued Funding to Develop RNAi Therapeutics for Biological Threats
07 August 2008
Commitment for continued funding of $7.5 million supports Alnylam biodefense™ efforts and broad technology development.

Metabolon and LS9 Partner to Apply Metabolomics to Biofuel Research and Production
30 July 2008
Applying Metabolon’s global biochemical profiling services, researchers will seek to identify changes in metabolites occurring during biofuel production.

Alnylam Grants New InterfeRx™ Intellectual Property License to Calando
22 July 2008
New target-specific license provides non-exclusive access to Alnylam intellectual property for an RNAi therapeutic product.

MorphoSys and Integrated BioTherapeutics Provide Update Regarding USAMRIID Biodefense Project
16 July 2008
IBT receives a five-year, NIH research grant to develop human antibody therapeutics against staphylococcal enterotoxin B.

Codon Devices and Algenol Biofuels Announce Partnership for Development of Biofuels from Algae
11 July 2008
The multi-year partnership will utilize Codon’s proprietary BioLOGIC™ protein engineering platform.

GENEART Receives a Grant for the Targeted Design of Vaccine Candidates
10 July 2008
GENEART participates in a joint project to develop a novel vaccine technology by designing a vaccine against the H5N1 avian influenza virus as a test case.

UT Southwestern Researchers Identify New Targets for RNAs that Regulate Genes
09 July 2008
RNA experts found that RNA can interact with a non-gene region of DNA called a promoter region.

Automating DNA Isolation from Cereal Crops with Tecan’s Magnetic Bead Technology
04 July 2008
Researchers have developed a semi-automated procedure for extracting and isolating high quality DNA from cereal crops Te-MagS™ platform.

  
Select Conferences